J. Berger

W. Sheremata, W. Harrington, J. Berger, 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Political Correctness of Medical Documentation.

J. Berger, 2015, JAMA neurology.

Molluscum contagiosum in the setting of Fingolimod: The experience at one institution.

J. Berger, Sabine Schneider, D. Do, 2021, Multiple sclerosis and related disorders.

Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy

E. Major, B. Curfman, C. Tornatore, 1992, Annals of neurology.

Classifying PML risk with disease modifying therapies.

J. Berger, 2017, Multiple sclerosis and related disorders.

The basis for modeling progressive multifocal leukoencephalopathy pathogenesis.

J. Berger, 2011, Current opinion in neurology.

CT, MR, and pathology in HIV encephalitis and meningitis.

R. Quencer, W. Sheremata, G. Maul, 1988, AJR. American journal of roentgenology.

The relationship of CPE to HIV dementia

D. Clifford, J. Berger, 2014, Neurology.

401 – Neurologic Complications of Human Immunodeficiency Virus Infection

A. Nath, J. Berger, 2012 .

Myelopathy and coinfection with HIV and HTLV-I

J. Berger, 1997, Neurology.

Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event

J. Berger, P. Brunetta, P. Lehane, 2018, Journal of NeuroVirology.

Progressive multi‐focal leucoencephalopathy among ibrutinib‐treated persons with chronic lymphocytic leukaemia

J. Armitage, C. Bennett, D. Raisch, 2018, British journal of haematology.

Progressive multifocal leukoencephalopathy in a patient with Hodgkin lymphoma treated with brentuximab vedotin

N. Bartlett, J. Berger, A. Cashen, 2012, Leukemia & lymphoma.

Predictors of severity and functional outcome in natalizumab-associated progressive multifocal leukoencephalopathy

R. Gold, A. Chan, R. Schneider, 2017, Multiple sclerosis.

A Programme for Risk Assessment and Minimisation of Progressive Multifocal Leukoencephalopathy Developed for Vedolizumab Clinical Trials

J. Provenzale, E. Major, D. Clifford, 2018, Drug Safety.

Progressive multifocal leukoencephalopathy after fingolimod treatment

B. Hemmer, M. Merschhemke, B. Ward, 2018, Neurology.

Varicella vaccination after fingolimod: A case report.

J. Berger, 2013, Multiple sclerosis and related disorders.

Delayed fingolimod-associated asystole

P. Espinosa, J. Berger, 2011, Multiple sclerosis.

Progressive multifocal leukoencephalopathy after ﬁ ngolimod treatment

B. Hemmer, M. Merschhemke, B. Cree, 2022 .

Risk Assessment and Minimization for Progressive Multifocal Leukoencephalopathy (PML RAMP): A Program to Assess for Potential Early Signs and Symptoms of PML during Clinical Development of Vedolizumab: 1673

J. Provenzale, E. Major, D. Clifford, 2013 .

Progressive Multifocal Leukoencephalopathy.

J. Berger, Elena Grebenciucova, 2018, Neurologic clinics.

The bone marrow, B cells, and JC virus

J. Berger, S. Houff, 2011, Journal of NeuroVirology.

JC virus detection in bodily fluids: clues to transmission.

Craig S. Miller, R. Kryscio, J. Berger, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The manifold faces of PML and the challenge of diagnosis

D. Clifford, J. Berger, 2011, Neurology.

Case definitions for progressive multifocal leucoencephalopathy: a step in the right direction

J. Berger, 2012, Journal of Neurology, Neurosurgery & Psychiatry.

Association of Bilateral Internuclear Oph-thalmoplegia and Myelomeningocele with Arnold-Chiari Malformation , Type II . . . . 124

Glaser, S. Kursunoglu, J. Yeakley, 2019 .

Diagnostic assays for polyomavirus JC and progressive multifocal leukoencephalopathy

K. Khalili, M. White, J. Gordon, 2016, Reviews in medical virology.

Reply to “‘Thinking without thinking’ about natalizumab and PML”

J. Berger, S. Houff, 2008, Journal of the Neurological Sciences.

Progressive Multifocal Leukoencephalopathy [ version 1 ; peer review : 2 approved ]

J. Berger, Laura A. Adang, 2022 .

Progressive Multifocal Leukoencephalopathy

J. Berger, Laura A. Adang, 2015, F1000Research.

Parinaud syndrome heralding MS

J. Berger, H. O'halloran, W. B. Lee, 2003, Neurology.

Podcast on B Cell-Targeting Therapies and Other Multiple Sclerosis Concerns During COVID-19

J. Berger, P. Repovic, Robert K Shin, 2022, Neurology and Therapy.

Improving risk‐stratification of natalizumab‐associated PML

J. Berger, Bastian Tugemann, 2021, Annals of clinical and translational neurology.

Spinal cord progressive multifocal leukoencephalopathy detected premortem by MRI

J. Schmitt, J. Woo, J. Berger, 2015, Journal of NeuroVirology.

Posterior reversible encephalopathy syndrome masquerading as progressive multifocal leukoencephalopathy in rituximab treated neuromyelitis optica.

Charles D. Smith, J. Berger, F. Cambi, 2014, Multiple sclerosis and related disorders.

Acute multifocal placoid pigment epitheliopathy and central nervous system involvement: nine new cases and a review of the literature.

D. Nicolle, J. Selhorst, J. Berger, 2001, Ophthalmology.

Benign focal cerebral vasculitis

M. Norenberg, J. Berger, M. Norenberg, 1995, Neurology.

Tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM): treatment with an anabolic steroid danazol.

W. Sheremata, W. Harrington, J. Berger, 1991, AIDS research and human retroviruses.

Persistent Coxsackie B encephalitis: Report of a case and review of the literature

G. Nuovo, C. Given, J. Berger, 2006, Journal of NeuroVirology.

Spinal Epidural Abscess

J. Berger, P. Krishnamohan, 2014, Current Infectious Disease Reports.

Active bleeding in hypertensive intracranial hemorrhage

R. Kelley, P. Scheinberg, J. Berger, 1983, Neurology.

Intensive Care Evaluation of the Comatose Patient

R. Daroff, J. Berger, 1982 .

Motor neuron disease: A paraneoplastic process associated with anti‐Hu antibody and small‐cell lung carcinoma

C. Petito, J. Berger, S. Snodgrass, 1996, Annals of neurology.

Paradoxically aggressive multiple sclerosis in the face of natalizumab therapy

J. Berger, J. Berger, 2008, Multiple sclerosis.

Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection: a review of the literature with a report of sixteen cases

M. Post, J. Berger, G. Dickinson, 1988 .

Misdiagnosis of multiple sclerosis in a female heterozygote with Fabry's disease.

J. Berger, 2019, Multiple sclerosis and related disorders.

Too much of a good thing?

J. Berger, 2011, Neurology.

Asymptomatic and neurologically symptomatic HIV-seropositive individuals: prospective evaluation with cranial MR imaging.

R. Quencer, J. Berger, M. Post, 1991, Radiology.

Sorting out the risks in progressive multifocal leukoencephalopathy

L. Calabrese, J. Berger, E. Molloy, 2015, Nature Reviews Rheumatology.

Ziconotide Infusion for Severe Chronic Pain: Case Series of Patients with Neuropathic Pain

J. Berger, D. Wermeling, 2006, Pharmacotherapy.

Iatrogenic Fungal Infections of Central Nervous System

J. Berger, S. Lahoti, 2013, Current Neurology and Neuroscience Reports.

Association of '(tropical) ataxic neuropathy' with HTLV-II.

L. Resnick, W. Sheremata, W. Harrington, 1993, Virus research.

Neurological infections: the year of PML and influenza

J. Berger, S. Houff, 2010, The Lancet Neurology.

Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome: Explaining the high incidence and disproportionate frequency of the illness relative to other immunosuppressive conditions

J. Berger, 2011, Journal of NeuroVirology.

Isolated Histoplasma capsulatum Meningoencephalitis in an Immunocompetent Child

J. Berger, Zachary D. Threlkeld, R. Broughton, 2012, Journal of child neurology.

Other opportunistic infections of the central nervous system in AIDS.

B. Cohen, J. Berger, 2007, Handbook of clinical neurology.

Isolated central nervous system histoplasmosis in an immunocompetent patient: 53-month hiatus to diagnosis and treatment

J. Berger, R. Greenberg, 2011, Journal of Neurovirology.

Isolated central nervous system histoplasmosis in an immunocompetent patient: 53-month hiatus to diagnosis and treatment.

J. Berger, R. Greenberg, 2010, Journal of neurovirology.

AIDS and Other Immunocompromised States

R. Dix, R. Levy, J. Berger, 1990 .

HIV and the central nervous system

J. Berger, M. Bensalem, 2002, Comprehensive therapy.

Cryptococcal Meningitis Reported With Fingolimod Treatment Case Series

J. Berger, M. Poeta, T. Hach, 2022 .

Neurological and Ophthalmological Manifestations of Varicella Zoster Virus

S. Kedar, J. Berger, Lakshman N Jayagopal, 2019, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

CNS fungal infections: A review

J. Berger, Cody L. Nathan, Brian E Emmert, 2021, Journal of the Neurological Sciences.

Central nervous system opportunistic infections.

J. Berger, A. Schneider, D. Wright, 1997, Neuroimaging clinics of North America.

Progressive multifocal leukoencephalopathy complicating Wiskott-Aldrich syndrome. Report of a case and review of the literature of progressive multifocal leukoencephalopathy with other inherited immunodeficiency states.

E. Major, M. Post, J. Berger, 1994, Archives of neurology.

The Neurologic Complications of Scleromyxedema

J. Berger, W. Maragos, M. Terhune, 2001, Medicine.

Neurosyphilis in AIDS

A. Berger, J. Berger, Aaron J. Berger, 2009 .

The neurologic complications of human immunodeficiency virus infection.

R. Levy, J. Berger, Joseph R. Berger, 1993, The Medical clinics of North America.

The neurological complications of bariatric surgery.

J. Berger, 2004, Archives of neurology.

Contralateral Optic Neuritis Following Silicone Oil Endotamponade for Retinal Detachment

P. Espinosa, Charles D. Smith, J. Berger, 2016 .

Neurosyphilis.

J. Berger, D. Dean, Dawson F. Dean, 2014, Handbook of clinical neurology.

High Prevalence of Multiple Human Herpesviruses in Saliva from Human Immunodeficiency Virus-Infected Persons in the Era of Highly Active Antiretroviral Therapy

Craig S. Miller, R. Kryscio, J. Berger, 2006, Journal of Clinical Microbiology.

Low prevalence of varicella zoster virus and herpes simplex virus type 2 in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy.

Craig S. Miller, R. Kryscio, J. Berger, 2010, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

Neurological complications of herpes simplex virus type 2 infection.

J. Berger, S. Houff, 2008, Archives of neurology.

The interface of infectious disease and neuro-ophthalmology.

J. Berger, 2012, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

Amebic infections of the central nervous system

J. Berger, 2022, Journal of NeuroVirology.

Human immunodeficiency virus type 1 infection of the brain

E. Major, C. Tornatore, W. Atwood, 1993, Clinical Microbiology Reviews.

Memory and the mammillothalamic tract.

J. Berger, 2004, AJNR. American journal of neuroradiology.

HIV dementia: the role of the basal ganglia and dopaminergic systems

G. Arendt, J. Berger, J. Berger, 2000, Journal of psychopharmacology.

Expression of miR-15/107 Family MicroRNAs in Human Tissues and Cultured Rat Brain Cells

Craig S. Miller, Robert J. Danaher, Christopher M. Norris, 2014, Genom. Proteom. Bioinform..

The neurologic complications of bariatric surgery.

J. Berger, D. Singhal, 2014, Handbook of clinical neurology.

HIV dementia and the basal ganglia.

A. Nath, J. Berger, 1997, Intervirology.

Cerebrospinal fluid dopamine in HIV‐1 infection

B. Levin, Mahendra Kumar, J. Berger, 1994, AIDS.

Molecular targets of opiate drug abuse in neuro AIDS

A. Nath, A. Bruce-Keller, P. Knapp, 2005, Neurotoxicity Research.

COVID-19 and MS disease-modifying therapies

A. Bar-Or, J. Berger, R. Brandstadter, 2020, Neurology: Neuroimmunology & Neuroinflammation.

Neurological Complications of Antiviral Vaccines

G. Fenichel, J. Berger, 2003 .

Importance and hurdles to drug discovery for neurological disease

D. Choi, E. Feldman, M. Gordon, 2013, Annals of neurology.

Multiple sclerosis‐like illness occurring with human immunodeficiency virus infection

M. Norenberg, L. Resnick, M. Fletcher, 1989, Neurology.

Chronic inflammatory polyradiculoneuropathy complicated by factor VIII antibody

W. Rosenfeld, W. Sheremata, J. Berger, 1983, Neurology.

Neurological Complications of Ethylene Glycol Intoxication

J. Berger, D. Ayyar, Meyer Js, 2016 .

Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain

E. Major, C. Tornatore, J. Berger, 1992, Clinical Microbiology Reviews.

Early penetration of the blood‐brain‐barrier by HIV

L. Resnick, W. Tourtellotte, P. Shapshak, 1988, Neurology.

Neurosyphilis in acquired immunodeficiency syndrome.

J. Berger, D. Katz, Debra A. Katz, 1989, Archives of neurology.

HIV‐1 infection of subcortical astrocytes in the pediatric central nervous system

E. Major, C. Tornatore, J. Berger, 1994, Neurology.

Substantia nigra depigmentation and exposure to encephalitis lethargica

G. Jicha, J. Vitek, J. Berger, 2012, Annals of neurology.

A double‐blind study comparing carbamazepine with phenytoin as initial seizure therapy in adults

B. Wilder, R. Ramsay, J. Bruni, 1983, Neurology.

Acceleration of HIV dementia with methamphetamine and cocaine

Frederick A. Schmitt, Malcolm J. Avison, Joseph R. Berger, 2011, Journal of NeuroVirology.

Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation.

M. Post, J. Berger, M. Whiteman, 1993, Radiology.

Neurosyphilis and the spinal cord: then and now.

J. Berger, 2011, The Journal of nervous and mental disease.

Infectious Myelopathies

J. Berger, 2011, Continuum.

Spinal cord syphilis associated with human immunodeficiency virus infection: a treatable myelopathy.

J. Berger, Joseph R. Berger, 1992, The American journal of medicine.

Monofocal Acute Inflammatory Demyelination (MAID): A Unique Disorder Simulating Brain Neoplasm

H. Jones, J. Gutrecht, J. Berger, 2002, Southern medical journal.

Definition and Consensus Diagnostic Criteria for Neurosarcoidosis: From the Neurosarcoidosis Consortium Consensus Group

D. Clifford, R. Baughman, J. Tavee, 2018, JAMA neurology.

CHAPTER 49 – Thermal Injury of the Nervous System

J. Berger, M. Dobbs, 2009 .

A giant MS plaque mimicking PML during natalizumab treatment

J. Berger, C. Twyman, 2010, Journal of the Neurological Sciences.

Next-generation sequencing of tissue

M. Wilson, J. Berger, 2016, Neurology: Neuroimmunology & Neuroinflammation.

Hereditary hemorrhagic telangectasia and spinal cord infarct: Case report with a review of the neurological complications of HHT

P. Espinosa, L. Pettigrew, J. Berger, 2008, Clinical Neurology and Neurosurgery.

Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare.

M. Concha, J. Berger, Joseph R. Berger, 1995, Journal of neurovirology.

Guillain-Barré syndrome complicating acute hepatitis B. A case with detailed electrophysiological and immunological studies.

W. Sheremata, J. Berger, R. Ayyar, 1981, Archives of neurology.

Cerebrovascular disease in young, HIV-infected, black Africans in the KwaZulu Natal province of South Africa.

M. Rayens, J. Berger, J R Berger, 2000, Journal of neurovirology.

Diagnostic value for culture of cerebrospinal fluid from HIV‐1-infected individuals for opportunistic viruses: a prospective study

R. Dix, J. Berger, M. McCarthy, 1994, AIDS.

Reactivation of JC virus and development of PML in patients with multiple sclerosis

F. Lublin, K. Khalili, M. White, 2007, Neurology.

COVID-19 and the nervous system

J. Berger, 2020, Journal of NeuroVirology.

Encephalitis lethargica (von Economo's encephalitis).

J. Vilensky, J. Berger, 2014, Handbook of clinical neurology.

A case of idiopathic recurrent inflammatory facial nerve paralysis

J. Berger, L. Zuroff, 2022, Neuroimmunology Reports.

CSF pleocytosis and syndrome of inappropriate antidiuretic hormone secretion in Creutzfeldt-Jakob disease.

J. Berger, D. Jacobs, A. Hamedani, 2016, Neurology. Clinical practice.

Is the presence of antibodies in CSF sufficient to make a definitive diagnosis of Lyme disease?

J. Berger, K. Roos, 2007, Neurology.

Cerebral ischemia and atrial fibrillation

R. Kelley, M. Alter, J. Berger, 1984, Neurology.

No association between vedolizumab exposure and serum JC virus levels.

D. Clifford, J. Berger, E. Fedyk, 2011 .

Disease-Modifying Therapy Adherence and Associated Factors in a National Sample of Medicare Patients With Multiple Sclerosis.

M. Jhaveri, Pengxiang Li, J. Doshi, 2020, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Intravascular lymphomatosis presenting with sudden hearing loss

J. Berger, Raleigh O. Jones, D. Wilson, 2005, Journal of the Neurological Sciences.

Impact of cervical stenosis on multiple sclerosis lesion distribution in the spinal cord.

J. Schmitt, P. Khankhanian, M. Schindler, 2020, Multiple sclerosis and related disorders.

The blood brain barrier in HIV infection.

M. Avison, J. Berger, 2004, Frontiers in bioscience : a journal and virtual library.

A risk classification for immunosuppressive treatment-associated progressive multifocal leukoencephalopathy

J. Berger, S. Chahin, 2014, Journal of NeuroVirology.

Progressive Multif ocal Leukoencephalopathy and Newer Biological Agents

J. Berger, 2010, Drug safety.

Memantine for AIDS Dementia Complex: Open-Label Report of ACTG 301

S. Lipton, Linda Chang, R. Ellis, 2010, HIV clinical trials.

Neuroimaging correlates of HIV-associated BBB compromise

F. Schmitt, M. Avison, A. Nath, 2004, Journal of Neuroimmunology.

Familial lipodystrophy associated with neurodegeneration and congenital cataracts

Simeon I. Taylor, J. Berger, Elif Arioglu Oral, 2002, Neurology.

Rapidly progressive dementia with hypoglycorrhachia

Jamie L. Adams, J. Siegler, J. Berger, 2015, Journal of clinical neuroscience.

Creutzfeldt‐Jakob disease in a physician

N. J. David, J. Berger, 1993, Neurology.

Limbic encephalitis associated with thymoma

M. Norenberg, N. J. David, J. Berger, 1990, Neurology.

Downbeat nystagmus with phenytoin.

J. Berger, A. Kovacs, 1982, Journal of clinical neuro-ophthalmology.

J. Berger, F. Zaheer, 2012, Therapeutic advances in drug safety.

Human immunodeficiency virus and bilateral optic atrophy

J. Berger, H. O'halloran, W. B. Lee, 2000 .

Cystinosis of the brain and spinal cord with associated vasculopathy

P. Nelson, B. Young, J. Berger, 2009, Journal of the Neurological Sciences.

CNS angiitis in graft vs host disease

D. Ježek, J. Berger, R. Baumann, 2002, Neurology.

PML diagnostic criteria

J. Sejvar, E. Major, D. Clifford, 2013, Neurology.

Progressive multifocal leukoencephalopathy in patients treated with rituximab: a 20-year review from the Southern Network on Adverse Reactions.

J. Armitage, C. Bennett, C. Nabhan, 2021, The Lancet. Haematology.

Infection Risk in Patients on Multiple Sclerosis Therapeutics

J. Berger, E. Williamson, 2015, CNS Drugs.

Management approach including pembrolizumab for fingolimod-associated progressive multifocal leukoencephalopathy in a patient with relapsing-remitting multiple sclerosis

S. Dizdarevic, L. Fisniku, R. Nicholas, 2022, Multiple sclerosis.

Progressive multifocal leukoencephalopathy

J. Berger, 2007, Seminars in neurology.

Cerebellar degeneration associated with human immunodeficiency virus infection

M Tagliati, R. Schwartz, D. Clifford, 1998, Neurology.

Reassessing the risk of natalizumab-associated PML

R. Fox, J. Berger, 2016, Journal of Neurovirology.

Multiple sclerosis remission following antiretroviral therapy in an HIV-infected man

J. Berger, Joshua Chalkley, 2014, Journal of NeuroVirology.

Monoclonal antibodies and progressive multifocal leukoencephalopathy

E. Major, J. Berger, S. Houff, 2009, mAbs.

Progressive multifocal leukoencephalopathy.

J. Berger, 2014, Handbook of clinical neurology.

Epidemiological evidence and molecular basis of interactions between HIV and JC virus

A. Nath, A. Chauhan, J. Berger, 2011, Journal of NeuroVirology.

Progressive Multifocal Leukoencephalopathy (PML)

J. Berger, 2003 .

The curious incident of the dog in the nighttime: does the absence of virus replication in Epstein-Barr virus-transformed B cells point to an important feature of JC virus biology?

J. Berger, S. Houff, 2010, The Journal of infectious diseases.

378 – Cytomegalovirus, Epstein-Barr Virus, and Slow Virus Infections of the Central Nervous System

A. Nath, J. Berger, 2012 .

Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia

Rodney A. Bales, F. Schmitt, M. Avison, 2011, Journal of NeuroVirology.

Understanding pathogenesis and treatment of HIV dementia: a role for magnetic resonance?

M. Avison, A. Nath, J. Berger, 2002, Trends in Neurosciences.

Short communication Intravascular lymphomatosis presenting with sudden hearing loss

J. Berger, Raleigh O. Jones, D. Wilson, 2005 .

Pearls: neurologic complications of HIV/AIDS.

J. Berger, 2010, Seminars in neurology.

Neurosurgical aspects of human immunodeficiency virus infection.

R. Levy, J. Berger, 1992, Neurosurgery clinics of North America.

Neurosyphilis in patients infected with human immunodeficiency virus

J. Berger, M. McCarthy, 1990, Annals of neurology.

JC virus antibody status underestimates infection rates

Craig S. Miller, J. Berger, R. Danaher, 2013, Annals of neurology.

Considerations on discontinuing natalizumab for the treatment of multiple sclerosis

D. Centonze, X. Montalban, C. Polman, 2010, Annals of neurology.

Progressive multifocal leukoencephalopathy

J. Berger, 2000, Current neurology and neuroscience reports.

Multifocal neutrophilic meningoencephalitis: a novel disorder responsive to anakinra

Z. Mourelatos, P. Merkel, R. Kolster, 2021, Journal of Neurology.

COVID-19 and the nervous system

J. Berger, 2020, Journal of NeuroVirology.

Guilty by association: Epstein–Barr virus in multiple sclerosis

A. Bar-Or, P. Lieberman, B. Banwell, 2022, Nature Medicine.

Genetic testing and HIV dementia: teasing out the molecular mechanisms of disease.

J. Berger, J. Rappaport, 2010, AIDS.

Re-evaluating the incidence of natalizumab-associated progressive multifocal leukoencephalopathy.

J. Berger, J. Borchardt, 2016, Multiple sclerosis and related disorders.

Neurologic consequences of autoimmune polyglandular syndrome type 1

J. Berger, J. Greenlee, Allison Weaver, 2008, Neurology.

Neuro-AIDS in the developing world

J. Berger, D. Dean, 2012, Neurology.

GLOBAL PERSPECTIVES

J. Berger, D. Dean, 2012 .

HIV ENCEPHALOPATHY: CLINICAL AND DIAGNOSTIC CONSIDERATIONS

J. Berger, R. Kaderman, 1995 .

Identification of potential antibody markers in HIV-associated dementia

S. Schutzer, J. Berger, M. Brunner, 2004, Journal of Neuroimmunology.

Autoimmune markers in HIV-associated dementia

H. Fillit, S. Schutzer, J. Berger, 2003, Journal of Neuroimmunology.

Detecting multiple sclerosis mimics early

J. Berger, D. Singhal, 2012 .

The hot bath test and multiple sclerosis.

W. Sheremata, J. Berger, 1982, JAMA.

Alien hand syndrome

P. Espinosa, Charles D. Smith, J. Berger, 2006, Neurology.

VIDEO Alien hand syndrome

P. Espinosa, Charles D. Smith, J. Berger, 2006 .

Clinical instrument to retrospectively capture levels of EDSS.

A. Cross, A. Salter, J. Berger, 2019, Multiple sclerosis and related disorders.

The effect of dimethyl fumarate (Tecfidera™) on lymphocyte counts: A potential contributor to progressive multifocal leukoencephalopathy risk.

B. Khatri, J. Berger, John F Kramer, 2015, Multiple sclerosis and related disorders.

Commentary: Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies

J. Berger, H. Hartung, 2023, Frontiers in Neurology.

Reassessing the risk of natalizumab-associated PML

R. Fox, J. Berger, 2016, Journal of NeuroVirology.

Varicella zoster virus rhombencephalomyelitis following radiation therapy for oropharyngeal carcinoma

Marisa S. Prelack, J. Berger, K. Patterson, 2016, Journal of Clinical Neuroscience.

Cerebrospinal Fluid 5-Hydroxytryptamine and 5-Hydroxyindoleacetic Acid in HIV-1 Infection

K. Goodkin, C. Eisdorfer, Mahendra Kumar, 2001, Neuropsychobiology.

Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study.

K. Tyler, O. Khan, S. Millis, 2009, Archives of neurology.

Active bleeding in hypertensive intracerebral hemorrhage

R. Kelley, P. Scheinberg, J. Berger, 1982, Neurology.

Thyroid function in Parkinson disease

R. Kelley, J. Berger, 1981, Neurology.

Sequential cranial MR findings of asymptomatic and neurologically symptomatic HIV+ subjects.

R. Quencer, B. Levin, J. Berger, 1992, AJNR. American journal of neuroradiology.

Progressive multifocal leukoencephalopathy in HIV‐1-infected children

E. Major, C. Tornatore, J. Berger, 1992, AIDS.

Persistent neurological deficit precipitated by hot bath test in multiple sclerosis.

W. Sheremata, J. Berger, 1983, JAMA.

The “Bedsheet” Babinski

J. Berger, M. Fannin, 2002, Southern medical journal.

Neurologic complications of human immunodeficiency virus infection. What diagnostic features to look for.

J. Berger, 1987, Postgraduate medicine.

A risk classification for immunosuppressive treatment-associated progressive multifocal leukoencephalopathy

J. Berger, S. Chahin, 2015, Journal of NeuroVirology.

Vaccines in Multiple Sclerosis

J. Berger, E. Williamson, S. Chahin, 2016, Current Neurology and Neuroscience Reports.

The pathogenesis of progressive multifocal leukoencephalopathy.

K. Khalili, J. Berger, 2011, Discovery medicine.

Progressive Multifocal Leukoencephalopathy and Relapsing-Remitting Multiple Sclerosis

K. Tyler, O. Khan, S. Millis, 2016 .

Erratum to: Reassessing the risk of natalizumab-associated PML

R. Fox, J. Berger, 2016, Journal of NeuroVirology.

Functional improvement and symptom management in multiple sclerosis: clinical efficacy of current therapies.

J. Berger, 2011, The American journal of managed care.

Response to Linberg et al. Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients

E. Major, J. Berger, S. Houff, 2008, Journal of Neuroimmunology.

Paraneoplastic Opsoclonus–myoclonus Secondary to Malignant Melanoma

J. Berger, E. Mehari, 2004, Journal of Neuro-Oncology.

Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids following influenza vaccination.

J. Berger, J. C. Parker, E. Escott, 2012, Archives of pathology & laboratory medicine.

The HIV Dementia Scale: Predictive power in mild dementia and HAART

Frederick A. Schmitt, Malcolm J. Avison, Joseph R. Berger, 2007, Journal of the Neurological Sciences.

JC Virus Reactivation with Natalizumab

J. Berger, 2009 .

Acute transitory cerebellar dysfunction associated with piperazine adipate.

E. Melamed, J. Berger, M. Globus, 1979, Archives of neurology.

HIV meningitis and dementia

J. McArthur, M. Avison, A. Nath, 2003 .

Relapsing and remitting human immunodeficiency virus—associated leukoencephalomyelopathy

E. Major, C. Tornatore, P. Shapshak, 1992, Annals of neurology.

P234 Vedolizumab does not reduce the CD4+:CD8+ ratio in the CSF of healthy volunteers

J. Berger, T. Wyant, C. Milch, 2012 .

Cerebrovascular disease in AIDS: a case‐control study

Jonathan O. Harris, J. Berger, J. O. Harris, 1990, AIDS.

HIV seropositivity in Guillain‐Barré syndrome

J. Berger, M. Swerdloff, J. Difini, 1987, Annals of neurology.

Varicella zoster virus (VZV) oculomeningoencephalomyeloradiculitis: a previously undescribed constellation

J. Berger, Etsegenet F. Tizazu, G. Chang, 2019, Journal of NeuroVirology.

Asymptomatic and neurologically symptomatic HIV-seropositive subjects: results of long-term MR imaging and clinical follow-up.

R. Quencer, L. Pall, J. Berger, 1993, Radiology.

Frequency and Phenotype of JC Virus-Specific CD8+ T Lymphocytes in the Peripheral Blood of Patients with Progressive Multifocal Leukoencephalopathy

D. Clifford, R. Gandhi, J. Berger, 2007, Journal of Virology.

Memantine for AIDS dementia complex

S. Lipton, Linda Chang, R. Ellis, 2010 .

Akinetic‐rigid syndrome in a 13‐year‐old girl with HIV‐related progressive multifocal leukoencephalopathy

W. Weiner, C. Singer, J. Berger, 1993, Movement disorders : official journal of the Movement Disorder Society.

THE NEUROLOGICAL COMPLICATIONS OF HIV INFECTION

J. Berger, 1988, Acta neurologica Scandinavica. Supplementum.

Vedolizumab does not reduce the CD4+:CD8+ ratio in the CSF of healthy volunteers: P-136.

J. Berger, T. Wyant, C. Milch, 2011 .

Letter re: Burnout, career satisfaction, and well-being among US neurologists in 2016

J. Berger, 2017, Neurology.

Neurologic Disease as the Presenting Manifestation of Acquired Immunodeficiency Syndrome

M. Fischl, R. Kelley, J. Berger, 1987, Southern medical journal.

Cytomegalovirus. Induced demyelination associated with acquired immune deficiency syndrome.

J. Berger, G. Hensley, L. Moskowitz, 1984, Archives of pathology & laboratory medicine.

Lamotrigine for HIV-associated painful sensory neuropathies

D. Clifford, R. Ellis, Y. So, 2003, Neurology.

Severe Neuroinvasive West Nile Virus in Association With Anti-CD20 Monotherapy for Multiple Sclerosis

A. Bar-Or, M. Wilson, M. Schindler, 2023, Neurology: Neuroimmunology & Neuroinflammation.

Progressive multifocal leukoencephalopathy.

J. Berger, 2007, Handbook of Clinical Neurology.

Spinal cord progressive multifocal leukoencephalopathy detected premortem by MRI

J. Schmitt, J. Woo, J. Berger, 2015, Journal of NeuroVirology.

Opportunistic infections of the nervous system in AIDS.

S. Lipton, I. Grant, H. Gendelman, 2005 .

Headache and human immunodeficiency virus infection: a case control study.

L. Pall, J. Berger, Joseph R. Berger, 1996, European neurology.

Reversible parkinsonian syndrome complicating cysticercus midbrain encephalitis

J. Sanchez-Ramos, J. Berger, B. Bowen, 1995, Movement disorders : official journal of the Movement Disorder Society.

Natalizumab and progressive multifocal leucoencephalopathy

J. Berger, J. Berger, 2006, Annals of the rheumatic diseases.

Neurologists: the last bedside physician-scientists.

J. Berger, 2013, JAMA neurology.

Balint's syndrome in subacute HIV encephalitis.

J. Berger, T. Whigham, 1993, Journal of Neurology Neurosurgery & Psychiatry.

Cerebrovascular changes in the basal ganglia with HIV dementia

A. Andersen, M. Avison, M. Avison, 2000, Neurology.

The interface of infectious disease and neuro-ophthalmology.

J. Berger, 2012, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

Other opportunistic infections of the central nervous system in AIDS.

B. Cohen, J. Berger, 2007, Handbook of clinical neurology.

Acute central cord syndrome with bodybuilder sign

P. Espinosa, J. Berger, 2007, Clinical Neurology and Neurosurgery.

Vedolizumab, a monoclonal antibody to the gut homing α4β7 integrin, does not affect cerebrospinal fluid T-lymphocyte immunophenotype

J. Berger, T. Wyant, A. Parikh, 2013, Journal of Neuroimmunology.

Presumptive human herpesvirus 6 myelopathy in an immunocompetent patient

R. Kelley, J. Berger, B. Kelley, 2014, Journal of NeuroVirology.

Presumptive human herpesvirus 6 myelopathy in an immunocompetent patient

R. Kelley, J. Berger, B. Kelley, 2015 .

Learning More About HHV-6 Encephalitis

J. Berger, 2021, Neurology: Neuroimmunology & Neuroinflammation.

Cryptococcal Meningitis Reported With Fingolimod Treatment

M. Del Poeta, B. Hemmer, B. Cree, 2022, Neurology: Neuroimmunology & Neuroinflammation.

Role of CD4+ and CD8+ T-Cell Responses against JC Virus in the Outcome of Patients with Progressive Multifocal Leukoencephalopathy (PML) and PML with Immune Reconstitution Inflammatory Syndrome

L. Ngo, D. Clifford, S. Kesari, 2011, Journal of Virology.

Total Tau Level in Cerebrospinal Fluid as a Predictor of Survival in Creutzfeldt-Jakob Disease: A Retrospective Analysis.

R. Shinohara, J. Berger, Danni Tu, 2023, Neurology. Clinical practice.